Recent studies revealed that cellular prion protein on neurons bind Alzheimer’s amyloid-β oligomers, causing neurotoxic effects. A new article in Cell Reports by Gunther and colleagues (Cell Rep. 2019; 26:145–158) shows that an orally administered cellular prion protein antagonist can rescue synaptic and cognitive deficits in Alzheimer’s mice overexpressing amyloid-β.